Arkolith/Insider Trading/VAXX/Form 4

Reese Lou

See Remarks, DirectorVaxxinity, Inc. (VAXX) · full profile →Form 4 · filed Apr 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2023Grant(A)620K—$0620K
Mar 7, 2023Grant(A)301K—$0301K
Mar 7, 2023Grant(A)62K—$062K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-010755) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML